The latest Cefic Chemical Trends Report Q1 2026 highlights one statistic that deserves the attention of every commodity chemical buyer. EU27 chemical capacity utilisation remains at approximately 74%, well below its long-term average and consistently below overall manufacturing utilisation across the European Union.
The report also shows chemical production declining 3.2% year on year during Q1 2026, with the sharpest weakness affecting other organic basic chemicals and polymers. For procurement professionals, these figures explain why many European producers are simultaneously reducing costs, closing selected facilities and competing aggressively for business. These are not contradictory actions. They are different responses to the same economic reality.
What Does 74% Capacity Utilisation Mean?
Capacity utilisation measures how much of a plant's available production capability is actually being used.
A facility designed to produce one million tonnes annually but operating at 74% utilisation is manufacturing only about three-quarters of its potential output. The remaining capacity sits idle while many operating costs continue.
This distinction is important because chemical manufacturing involves significant fixed costs that do not disappear when production slows.
These include:
Plant maintenance and inspections that must continue regardless of output.
Skilled employees needed to operate and maintain complex production assets.
Utilities and infrastructure required to keep facilities operational.
Regulatory compliance and environmental monitoring.
Lower production spreads these fixed costs across fewer tonnes of product, increasing the cost of each unit produced.
Why European Producers Are Cutting Costs
Operating at 74% utilisation places sustained pressure on profitability.
With lower sales volumes, producers seek efficiencies throughout their organisations to improve financial performance without sacrificing operational reliability.
Common measures include:
Streamlining manufacturing operations to improve efficiency.
Reducing discretionary spending and administrative costs.
Optimising procurement and logistics.
Delaying non-essential capital projects.
These initiatives help companies remain competitive while market demand remains below historical levels.
Why Some Plants Are Closing Instead of Waiting
At first glance, plant closures may seem inconsistent with low utilisation.
If spare capacity already exists, why reduce it further?
The answer lies in production economics.
Not every manufacturing facility has the same operating costs or efficiency. Older plants or smaller production units may struggle to recover even their variable operating costs during prolonged market weakness.
In these cases, permanent closure can improve the performance of the wider production network by concentrating manufacturing at more competitive sites.
For buyers, this explains why companies may reduce overall capacity even while maintaining significant unused production capability elsewhere.
The Difference Between Spare Capacity and Healthy Capacity
A market operating at 74% utilisation still has the ability to increase production relatively quickly if demand improves.
This provides flexibility for suppliers because they can raise output without immediately investing in new manufacturing facilities.
However, low utilisation also limits the financial resources available for future investment.
When facilities consistently operate below optimal levels:
Fixed-cost recovery weakens.
Cash flow available for expansion declines.
Capital reinvestment becomes more selective.
Companies prioritise maintaining competitive assets over expanding capacity.
This balance explains much of the current strategic behaviour across Europe's commodity chemical sector.
Which Chemical Segments Face the Greatest Pressure?
According to the latest market data, the weakest performance remains concentrated in other organic basic chemicals and polymers.
These commodity sectors are particularly sensitive to industrial demand, construction activity and manufacturing output. When downstream industries reduce consumption, producers often experience immediate pressure on operating rates and profitability.
In contrast, several specialty chemical and consumer-oriented segments have shown greater resilience because they serve more diversified end markets and often benefit from higher-value product portfolios.
This divergence means procurement strategies should be tailored to individual product categories rather than assuming identical market conditions across the chemical industry.
What Low Utilisation Means for Pricing
Many buyers associate lower utilisation with falling prices, but the relationship is more complex.
Unused capacity increases competitive pressure because producers seek additional sales volumes. At the same time, weaker fixed-cost recovery encourages companies to protect margins wherever possible.
This creates two competing commercial forces:
The result is often a market where contract negotiations remain competitive while producers carefully manage pricing policies.
Procurement Strategies in a Low Utilisation Environment
Periods of below-average utilisation present opportunities for buyers that combine market intelligence with disciplined sourcing practices.
Procurement teams should consider:
Monitoring supplier financial performance alongside pricing trends.
Evaluating whether suppliers are investing in competitive production assets.
Maintaining relationships with multiple qualified producers.
Negotiating flexible supply agreements while capacity remains available.
Watching for announcements involving plant closures or network restructuring.
These measures help balance cost competitiveness with long-term supply security.
What Buyers Should Watch Through 2027
Cefic's Q1 2026 figures illustrate that Europe's chemical industry continues operating below historical capacity levels. The combination of 74% utilisation, declining production and selective plant closures reflects an industry adapting to structural market pressure rather than a short-lived slowdown.
For procurement professionals, the key takeaway is that spare capacity does not necessarily mean financially healthy producers. Companies must balance the ability to increase production quickly with the challenge of recovering fixed costs and funding future investment. Buyers who understand these utilisation economics will be better positioned to interpret supplier decisions, anticipate commercial behaviour and develop resilient sourcing strategies.
Ready to source commodity chemicals from verified global suppliers? Explore competitive offers on our platform today.